MEDICA 2024 and COMPAMED 2024 Showcase Latest Healthcare Trends with Exciting Innovations and Program Formats
|
By LabMedica International staff writers Posted on 11 Nov 2024 |
.jpg)
MEDICA (Düsseldorf, Germany) and COMPAMED 2024 being held in Düsseldorf from 11 to 14 November 2024 are once again welcoming visiting professionals from all fields of the international healthcare and medical technology industry. Last year, MEDICA and COMPAMED recorded a total of 83,000 visiting professionals from more than 160 countries. This year, 5,800 exhibitors from 72 countries are filling the entire hall space on the trade fair grounds. Their innovations highlight both events as globally unique information and business platforms serving the entire medical equipment supply chain – including manufacture and development.
An important new development this year is the themed hall selections in the MEDICA Med Tech & Devices and Digital Health areas, known as “spheres”, with the accompanying German Hospital Conference being held at a new location. To date, the flagship event for top managers of German hospitals was held at the Congress Center Düsseldorf; now it has been moved to the center of the trade fair in Hall 12. To get proceedings started, the North Rhine-Westphalian Minister of Health Karl-Josef Laumann is speaking to the delegates, focusing in particular on the changes in the German hospital landscape stemming from upcoming hospital reform. All around the event space, exhibiting organizations that fit the theme are grouped together, showcasing innovative developments for hospital equipment and operating theatres.
The world of experience Digital Health in Hall 13 also has some political relevance, for instance, the MEDICA ECON FORUM (health policy and economics in the context of digital transformation in healthcare. In addition, all the latest IT trends and digital innovations are hot topics for discussion. This is reflected in the program of events at the MEDICA HEALTH IT FORUM, the MEDICA INNOVATION FORUM as well as the Hospital of the Future special presentation (innovations around digital infrastructure in hospitals and data use, as demonstrated by the example of intensive care), the Wearable Technologies Show (high-tech products worn on the body) and the MEDICA START-UP PARK (a central hub for networking with the digitally powered start-up scene).
The MEDICA INNOVATION FORUM is also spotlighting high-flying women in the sector. The panel discussion titled “Together we thrive” features women who have been highly successful in the healthcare industry in various management positions, whether in large organizations or the dynamic start-up sector, making them ideal discussion partners with a wealth of experience. Among the panelists are Hadas Bitran, Partner General Manager, Health AI (Microsoft Health and Life Sciences), Ayelén Fernández, Global Orthotics & Prosthetics Segment Manager (HP), Audrey A. Sherman, Division Scientist (Solventum; previously 3M Healthcare) and Nina Wöss, Managing Partner (Female Founders).
The additional hot topics on stage at MEDICA 2024’s accompanying forums and conferences include current examples of applications for AI and robotics as well as assistance systems in day-to-day medical practice. Another area of focus is the increasing connectivity in healthcare provision, specifically on innovations for the point of care: diagnostics and treatment in the immediate vicinity of patients (usually outpatients). This includes telemedicine applications aimed at providing the best possible collaboration across sectors by all those involved in the treatment process. Another top issue at this year’s MEDICA is the urgent skills shortage. This is impacting almost all organizations in the healthcare sector, leading them to search for solutions. These solutions are being discussed in a focused manner at the individual forums and conferences – for example, from the particular perspective of laboratory medicine at the MEDICA LABMED FORUM (in Hall 1).
At MEDICA 2024, there are five spheres promising a wide variety of innovations for the treatment of outpatients and clinical use. These include robotic applications to support highly complex neurosurgical brain interventions as well as orthopedic operations (including hip implants), plus a novel drive system that can be fitted into most hospital beds. The drive system works like that of an e-bike and significantly eases the workload for staff at healthcare facilities during patient transport. Another new solution on show is a medically certified smartwatch for easy measurement of wrist blood pressure. The spheres at the trade fair are: Lab & Diagnostics, Med Tech & Devices, Disposables, Physio Tech and Digital Health.
This year at MEDICA, the Automotive Health special exhibition area has been created as a pop-up novelty. Nowadays, a number of sensors and functions can be built into cars to enable safe and healthy driving. Fatigue detection systems, which are already commonplace, are just one example. And there is a whole host of other possible features to examine health-relevant data measured from motorists and identify risk factors that could result in emergencies and potentially serious accidents. At the special exhibition area in Hall 12, the Innovation Institute is demonstrating its proven expertise in the field, exhibiting vehicles such as the VW ID.4, the VW Tiguan and a vintage Melkus sports car as well as a racing simulator. The institute’s key customers include Audi, Mercedes, Porsche and Volkswagen.
Halls 8a and 8b is also offering specialist knowledge in development. At COMPAMED 2024, 750 supplier organizations are exhibiting across five world spheres: Manufacturing & Devices (e.g., components, parts, manufacturing processes), Services & Advice (e.g., research, development, services), Materials (e.g., plastics, glass, ceramics, metals, composite materials, adhesives, packaging), Micro Tech (such as microcomponents and microfluidics) as well as IT in Tech (software development and maintenance for medical technology). Offering a specialized program of accompanying events, the COMPAMED HIGH-TECH FORUM and COMPAMED SUPPLIERS FORUM reflect leading topics within the supplier sector such as AI, robotics and automation, microtechnology developments, and material innovations.
It is not only in the exhibition halls that new developments are being highlighted in greater detail. Messe Düsseldorf’s new Trade Talk Today video podcast, which can be viewed on the home pages of the industry portals MEDICA.de and COMPAMED.de, is sharing important updates on innovations and event highlights, allowing visitors to start every day of the trade fair on schedule. Movers and shakers are offering their insights as well as contextualizing industry trends. In the run-up to the events, the new MEDICA AI Buddy is already hard at work. The virtual assistant is on hand to help all potential and registered visitors plan a particularly impactful trade fair visit. Attendees wishing to benefit from its support can find the AI Buddy on the home page of the MEDICA online portal as well as integrated into the MEDICA app.
Related Links:
MEDICA
Latest Medica 2024 News
- EDAN Instruments Highlights Range of Lab Analyzers, ECG Devices and Ultrasound Systems
- BioVendor Group Introduces Groundbreaking Immunological Biomarker
- Getein Biotech Showcases Latest POCT Analyzers
- Fapon Highlights Innovative IVD Total Solutions and Localization Services
- Wondfo Presents Advanced Solutions in CLIA Testing and Blood Gas Analysis
- Globe Scientific Exhibits Cutting-Edge Solutions for Meeting Laboratory Needs
- LGC Clinical Diagnostics Presents Seraseq and ACCURUN Range of Diagnostic Solutions
- Oruba Showcases Innovative Self-Operating Uroflowmeter
- Awareness Technology Showcases Range of Cutting-Edge Analyzers
- Sentinel Diagnostics Presents Latest Breakthroughs in Diagnostics
- Alcor Scientific Presents Latest Innovation in High Volume ESR Testing
- CerTest Showcases Latest Innovations in Diagnosis of Infectious Diseases
- Vircell Presents Latest Offerings and Products in Diagnostic Testing
- Tianlong Demonstrates Latest Biochemistry, Immunology, POCT and Molecular Diagnostic Products
- EKF Presents Cutting-Edge Point-Of-Care Diagnostic Solutions
- Vedalab Exhibits Rapid Diagnostic Tests
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read moreMolecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read moreAI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read morePathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read moreTechnology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read moreAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channelNew Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more








